Skip to main content
. 2015 Apr 15;8(4):6145–6153.

Table 5.

Comparison of primary symptome improvement, clinical efficacy and adverse reaction events between the two groups

Yingliu Treatment (40) Control Treatment (40)
Goiter Total efficacy score 21 10
Fatigue Total efficacy score 39▲▲ 30
Dry mouth and thirsty Total efficacy score 37 29
Clinical efficacy Cured 0 0
Marked efficient 14 6
Efficient 23 27
Invalid 3 7
Total effective rate (%) 92.50 82.50
Adverse reaction event Leukopenia 5 11
ALT elevation 5 1
Abnormal renal function 0 0
Rush 0 0
Safety evaluation Level 1 31 28
Level 2 2 4
Level 3 7 8
Level 4 0 0

Compared with control group,

P < 0.05;

▲▲

P < 0.01.